News

NEW CLINICAL STUDY ON HPV SELFY HAS BEEN PUBLISHED
NEW CLINICAL STUDY ON HPV SELFY HAS BEEN PUBLISHED

A new clinical study on HPV Selfy and self-collection

HPV SELFY: THE FIRST FULL GENOTYPING HPV TEST VALIDATED FOR PRIMARY CERVICAL CANCER SCREENING ON SELF-COLLECTED SAMPLES
HPV SELFY: THE FIRST FULL GENOTYPING HPV TEST VALIDATED FOR PRIMARY CERVICAL CANCER SCREENING ON SELF-COLLECTED SAMPLES

Ulisse BioMed is proud to announce an important milestone reached: the validation of HPV Selfy as a primary cervical cancer...

NEW SCIENTIFIC PUBLICATION IN SUPPORT OF A TECHNOLOGY PATENTED BY ULISSE BIOMED
NEW SCIENTIFIC PUBLICATION IN SUPPORT OF A TECHNOLOGY PATENTED BY ULISSE BIOMED

While the world continues fighting against COVID-19 pandemic, still SARS- CoV-2 virus and its variants evolution raises great...

ULISSE BIOMED PARTICIPATES IN EUROGIN 2022
ULISSE BIOMED PARTICIPATES IN EUROGIN 2022

Ulisse BioMed participated in EUROGIN 2022 (European Research Organization on Genital Infection and Neoplasia), which was held...

1 2 3 4